Incyte Biosciences Denmark ApS

CVR 35818790 · Private limited company (ApS) · Active · Low risk

Incyte Biosciences Denmark ApS is a Private limited company (ApS), founded on , based in Frederiksberg C. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 12 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 2.3m and a net result of DKK 361k. CEO: Ebba Cecilia Bröms.

Bankruptcy risk for Incyte Biosciences Denmark ApS

0.6%
probability of bankruptcy within 12 months
Low risk

0.4 × the average (1.41%) · higher risk than 66% of active Danish companies

Lowest riskHighest risk

Increases the risk

CEO changes in the last year2+ · bankruptcy rate 18.5%2.1×
Time since new CEO0.5–1 yrs · bankruptcy rate 15.6%1.8×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Annual reports filed late1 · bankruptcy rate 11.3%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Employees (latest year)2–5 · bankruptcy rate 10.3%1.2×
Other companies at the same address20–100 · bankruptcy rate 10.2%1.2×

Reduces the risk

Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Auditor's statementExtended review · bankruptcy rate 2.9%0.33×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Return on assets5%–15% · bankruptcy rate 3.5%0.39×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Gross profit growth-10%–0% · bankruptcy rate 4.3%0.49×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
35818790
Status
Active
Company type
Private limited company (ApS)
Founded
(12 years)
Address
Suomisvej 4
1927 Frederiksberg C
Municipality
Frederiksberg
Industry
Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr
Share capital
DKK 50k
Employees
2 (2018)
Auditor
Grant Thornton, Godkendt Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late1 of 12
Missing annual reportNo
Negative equityNo
Equity ratio58.1%
Current ratio236%
Moves (last 2 years)0
CEO changes in total4
CEO's previous bankruptcies0
Other companies at the address79
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 6.7mDKK 7.0m
Net profitDKK 361kDKK 369k
EquityDKK 2.3mDKK 2.0m
Total assetsDKK 4.0mDKK 3.7m
CashDKK 752k–
Short-term debtDKK 1.7m–
Avg. employees4–

Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Grant Thornton, Godkendt Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025191 Late
1 Jan 2024 – 31 Dec 2024177
1 Jan 2023 – 31 Dec 2023149
1 Jan 2022 – 31 Dec 2022137
1 Jan 2021 – 31 Dec 202196
1 Jan 2020 – 31 Dec 2020127
1 Jan 2019 – 31 Dec 2019141
1 Jan 2018 – 31 Dec 2018162
1 Jan 2017 – 31 Dec 2017113
1 Jan 2016 – 31 Dec 2016128
1 Jan 2015 – 31 Dec 2015153
1 Apr 2014 – 31 Dec 2014160

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOEbba Cecilia BrömsCurrent
CEOErik Thomas Fromm
CEOErik Garardus Johannes Bokmans
BoardLee Jason HeesonCurrent
BoardEbba Cecilia BrömsCurrent
BoardErik Thomas Fromm
BoardJonathan Elliot Dickinson
BoardErik Garardus Johannes Bokmans
Owner (100%)Incyte Biosciences International SàrlCurrent
Owner (100%)Incyte Biosciences Luxembourg Sàrl
Owner (100%)Incyte Biosciences Luxembourg Sàrl
AuditorGrant Thornton, Godkendt RevisionspartnerselskabCurrent
FounderKimara & co advokatanpartsselskabCurrent

Address history (2 moves)

Suomisvej 4, 1927 Frederiksberg C
Arne Jacobsens Allé 7, 5., 2300 København S
c/o Magnusson Advokatanpartsselskab, Frederiksgade 7, 3., 1265 København K

Former names

Incyte Biosciences Denmark ApS – now
ARIAD PHARMACEUTICALS (DENMARK) ApS –

Employees per year

Number of employees at Incyte Biosciences Denmark ApS per year122014: 120142015: 120152016: 120162017: 220172018: 22018

Other companies at the same address

Similar companies in Frederiksberg

Questions and answers about Incyte Biosciences Denmark ApS

Has Incyte Biosciences Denmark ApS gone bankrupt?

No, Incyte Biosciences Denmark ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of Incyte Biosciences Denmark ApS?

Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.

Who is the CEO of Incyte Biosciences Denmark ApS?

Ebba Cecilia Bröms is the CEO of Incyte Biosciences Denmark ApS.

Who is the auditor of Incyte Biosciences Denmark ApS?

Incyte Biosciences Denmark ApS most recently used Grant Thornton, Godkendt Revisionspartnerselskab.

When was Incyte Biosciences Denmark ApS founded?

Incyte Biosciences Denmark ApS was founded on 1 April 2014.

What is the equity of Incyte Biosciences Denmark ApS?

Equity was DKK 2.3m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.